Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Wockhardt ED Huzaifa...

    Wockhardt ED Huzaifa Khorakiwala to raise Rs 125 cr for health fund

    Written by savita thakur thakur Published On 2016-12-15T11:46:14+05:30  |  Updated On 15 Dec 2016 11:46 AM IST

    Executive Director of Wockhardt Ltd Huzaifa Khorakiwala has launched a healthcare angel fund that is targeting to raise Rs 125 crore to be invested in start-ups.


    Health Passion Fund is targeting to raise Rs 125 crore corpus and will look at an investment up to Rs 5 crore in each start-up, a statement said.



    The fund will seek to invest in around 30 healthcare start-ups of under 3 years of operations with qualified team, proof of concept, revenue & business traction. It will focus on emerging firms using technology as an enabler or driver in healthcare, it said.

    Having managed and grown a healthcare unicorn in India, Khorakiwala, the scion of the Wockhardt family, wants to strengthen the healthcare start-up ecosystem and support creation of more healthcare unicorns from India.

    "India's healthcare vertical touching USD 150 billion needs a lot more disruptive ideas to provide new age solutions to conventional health problems. The scale of unserved markets need technology enablers to solve conventional health problems and this needs encouragement and support of industry players.

    "Global precedents show this can reduce cost and response time, and increase efficiency of the sector. Besides, this can create more domestic jobs," the statement quoted Khorakiwala as saying.

    "We will also help our funded start-ups to rollout a no-frill version of their product for the masses and thus create a well-funded basket of inclusive healthcare solutions for Indian masses."

    ProHealth Catalyst will be the investment advisor of the fund and its key members are Sumit K Mody and Anand Oswal.

    Prior to this, Mody led setting up of Healthcare Innovations Fund for Sunil Wadhwani of iGate, while Oswal has been Executive Director at UBS Singapore.

    Mody said, "Breaking from the tradition of deal showcasing and blind faith on fund manager's investment calls, our fund intends to provide our investors real time discretion to accept or reject each of our investment proposals.

    "Also, our sector-focused approach will allow us to do better integration of portfolio companies for exit, growth and further funding within the next 2-3 years.


    healthcare fundingHuzaifa Khorakiwalapharma newsRs 125 cr for health fundWockhardtWockhardt Ltd Huzaifa Khorakiwala
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok